- Data support baricitinib's ongoing Phase 3 program and potential to be the first approved medicine for people living with alopecia areata (AA)
PR Newswire
INDIANAPOLIS, Oct. 30, 2020
PR Newswire
INDIANAPOLIS, Oct. 30, 2020
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey